Mesenchymal stromal cell therapy: different sources exhibit different immunobiological properties

Transplantation. 2015 Jun;99(6):1113-8. doi: 10.1097/TP.0000000000000734.

Authors

Evgenios Neofytou¹, Tobias Deuse, Ramin E Beygui, Sonja Schrepfer

Affiliation

¹ 1 TSI Laboratory, University Heart Center Hamburg, Hamburg, Germany. 2 Department of Cardiothoracic Surgery, Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA. 3 Cardiovascular Research Center Hamburg (CVRC) and DZHK (German Center for Cardiovascular Research), partner site Hamburg/Kiel/Luebeck, Germany. 4 Cardiovascular Surgery, University Heart Center Hamburg, Hamburg, Germany.

PMID: 26035274
DOI: 10.1097/TP.0000000000000734

No abstract available

Publication types

Review

MeSH terms

Antigens, CD / metabolism
Cell Differentiation
Cell Separation
Cell- and Tissue-Based Therapy*
Cellular Senescence / immunology
Clinical Trials as Topic
Humans
Immunomodulation
Mesenchymal Stem Cell Transplantation
Mesenchymal Stem Cells / cytology
Mesenchymal Stem Cells / immunology*
Mesenchymal Stem Cells / physiology
Paracrine Communication
Regenerative Medicine

Substances

Antigens, CD